Moscow: Russia declared itself the first country to approve a coronavirus vaccine with President Vladimir Putin saying one of his daughters had been inoculated.
Naming the vaccine “Sputnik V” after the Soviet-era satellite that was the first launched into space, Russian officials said it provided safe, stable immunity and denounced Western attempts to undermine Moscow’s research.
“As far as I know, this morning for the first time in the world a vaccine against the novel coronavirus infection was registered,” Putin was quoted as saying as he opened a meeting with the state officials.
Putin informed that one of his daughters tested the Russian Covid-19 vaccine on herself and she is feeling well.
“I know this very well, because one of my daughters got vaccinated, so in this sense, she took part in testing,” Putin said.
“After the second shot, she had a slight fever again, and then everything was fine. She is feeling well and has a high [antibody] count,” the President informed.
Russia, however, faces international scepticism due to its fast approach in developing the vaccine.
The World Health Organization said any WHO stamp of approval on a COVID-19 vaccine candidate would require a rigorous safety data review.
The Russian vaccine is expected to enter into civilian circulation on January 1, 2021, the media reported, citing the registration certificate.
Russian Health Minister Mikhail Murashko said that teachers and medical workers will be the first to get the Covid-19 vaccine jointly developed by the Gamaleya Research Institute and the Russian Defense Ministry, the Tass news agency reported.
On August 3, a “final medical examination” of participants in clinical trials of the vaccine took place at the Burdenko Main Military Clinical Hospital, the Russian Defence Ministry had earlier said in a statement.
Of the six Covid-19 vaccine candidates that have reached the Phase 3 level according to the WHO, three are from China and the other three include the ones developed by the University of Oxford and AstraZeneca, Moderna, and one jointly developed by Pfizer and BioNTech.Read More